-+ 0.00%
-+ 0.00%
-+ 0.00%

Rosenblatt Maintains Buy on Dolby Laboratories, Lowers Price Target to $75

Benzinga·11/18/2026 12:33:24
Listen to the news
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $80 to $75.